Skip to content

James Robert Reed, M.D.

NPI 1790724524ActiveIndividual· Internal Medicine, Nephrology· Birmingham, AL

Internal Medicine, Nephrology (M.D.) in Birmingham, Alabama, licensed in AL, with an NPI issued in June 2006. Part D covered 52 prescriptions written in 2024, 92% of them generic. Otsuka America Pharmaceutical, Inc. reported $18.35 in payments in 2025, mostly food and beverage.

Overview

NPI1790724524
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJun 6, 2006
Last updated in NPPESApr 15, 2015

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Nephrology Primary207RN0300X7872AL

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)52 · 132 30-day fills
Total drug cost$833.96
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$18.35 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Otsuka America Pharmaceutical, Inc.$18.351

What the 2025 payments were for

  • Food and Beverage$18.35 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other nephrologists in Birmingham

All 78 nephrologists in Birmingham · All nephrologists in Alabama